Budigalimab [2098225-93-3]

TargetMol Chemicals

Budigalimab

9

2098225-93-3

Antibody

Research Use Only

Budigalimab

Budigalimab (ABBV 181; PR 1648817) is a humanized IgG1 monoclonal antibody that specifically targets the programmed cell death 1 (PD-1) receptor, featuring an Fc mutation to reduce interactions with the Fc receptor and minimize effector function [1].

3 years

-20°C

12352203